Bupropion for postpartum smoking relapse: A remote protocol for a two-arm, double-blind, placebo-controlled randomized clinical trial

Keyphrases

• Placebo-controlled 100%
• Randomized Clinical Trial 100%
• Bupropion 100%
• Postpartum Smoking Relapse 100%
• Remote Protocol 100%
• Placebo 60%
• Quit Smoking 60%
• Postpartum Women 40%
• Maternal Prenatal Smoking 40%
• Major Depressive Disorder 20%
• Healthy children 20%
• Public Health Risk 20%
• Placebo-controlled Randomized Trial 20%
• Relapse Prevention 20%
• Health Risk 20%
• Prevention Strategies 20%
• Secondhand Smoke Exposure 20%
• Cigarette Smoking 20%
• Post-randomization 20%
• Safety Concerns 20%
• Abstinence 20%
• Point-prevalence Abstinence 20%
• Postpartum Relapse Prevention 20%
• Smoking Relapse Prevention 20%
• Exposure to COVID-19 20%
• Staff Exposure 20%
• Smoke Modeling 20%
• Persistent Depressive Disorder 20%
• On-state Current 20%
• Prevention Tool 20%

Medicine and Dentistry

• Randomized Clinical Trial 100%
• Arm 100%
• Smoking Relapse 100%
• Bupropion 100%
• Placebo 100%
• Nicotine Withdrawal 60%
• Relapse Prevention 60%
• Abstinence 40%
• Smoking in Pregnancy 40%
• Disease 20%
• Public Health 20%
• Drug Therapy 20%
• Neonatal Infant 20%
• Randomized Controlled Trial 20%
• Prevalence 20%
• Major Depressive Episode 20%
• Health Hazard 20%
• Passive Smoking 20%
• Cigarette Smoking 20%
• COVID-19 20%
• Depression 20%